These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 182326)

  • 21. Dopamine receptor sensitivity in brain and retina of rats during aging.
    Govoni S; Loddo P; Spano PF; Trabucchi M
    Brain Res; 1977 Dec; 138(3):565-70. PubMed ID: 597726
    [No Abstract]   [Full Text] [Related]  

  • 22. Long-term changes in the sensitivity of pre-and postsynaptic dopamine receptors in mouse striatum evidenced by behavioural and biochemical studies.
    Martres MP; Costentin J; Baudry M; Marcais H; Protais P; Schwartz JC
    Brain Res; 1977 Nov; 136(2):319-37. PubMed ID: 922486
    [No Abstract]   [Full Text] [Related]  

  • 23. On the mechanism of morphine action on rat striatal dopamine metabolsim.
    McMillen BA
    Biochem Pharmacol; 1980 May; 29(10):1432-5. PubMed ID: 7396977
    [No Abstract]   [Full Text] [Related]  

  • 24. Behavioral effects of apomorphine and diisobutyrylapomorphine in the mouse.
    Baldessarini RJ; Kula NS; Walton KG
    Psychopharmacology (Berl); 1977 Jun; 53(1):45-53. PubMed ID: 407613
    [No Abstract]   [Full Text] [Related]  

  • 25. Blockade of central dopaminergic receptors of morphine: effect of haloperidol, apomorphine or benztropine.
    Puri SK; Reddy C; Lal H
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):389-401. PubMed ID: 4735501
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of morphine on striatal dopamine metabolism: possible mechanism of its opposite effect on locomotor activity in rats and mice.
    Kuschinsky K; Hornykiewicz O
    Eur J Pharmacol; 1974 Apr; 26(1):41-50. PubMed ID: 4598755
    [No Abstract]   [Full Text] [Related]  

  • 27. Dopaminergic influence on withdrawal jumping behavior in morphine-dependent mice.
    Tseng LF; Brase DA; Loh HH
    Res Commun Chem Pathol Pharmacol; 1976 Nov; 15(3):435-46. PubMed ID: 1033590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased sensitivity to dopaminergic agents after chronic neuroleptic treatment.
    Vonvoigtlander PF; Losey EG; Triezenberg HJ
    J Pharmacol Exp Ther; 1975 Apr; 193(1):88-94. PubMed ID: 166158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ontogenetic development of neostriatal dopamine receptors in the rat.
    Spano PF; Kumakura K; Govoni S; Trabucchi M
    J Neurochem; 1976 Aug; 27(2):621-4. PubMed ID: 987161
    [No Abstract]   [Full Text] [Related]  

  • 30. Dose-response shifts in the behavioural effects of dopamine agonists and antagonists following chronic morphine treatment.
    Overstreet DH; Smee ML; Woolston ME
    Proc West Pharmacol Soc; 1976; 19():248-53. PubMed ID: 1033554
    [No Abstract]   [Full Text] [Related]  

  • 31. Biochemical characterization of the dopamine receptor in the mammalian caudate nucleus.
    Greengard P
    J Psychiatr Res; 1974; 11():87-90. PubMed ID: 4156795
    [No Abstract]   [Full Text] [Related]  

  • 32. LSD and dopamine-sensitive adenylate-cyclase in various rat brain areas.
    Spano PF; Kumakura K; Tonon GC; Govoni S; Trabucchi M
    Brain Res; 1975 Jul; 93(1):164-7. PubMed ID: 166729
    [No Abstract]   [Full Text] [Related]  

  • 33. Hydrolysis of diester prodrugs of apomorphine.
    Baldessarini RJ; Kula NS; Walton KG; Borgman RJ
    Biochem Pharmacol; 1977 Oct; 26(19):1749-56. PubMed ID: 907714
    [No Abstract]   [Full Text] [Related]  

  • 34. Changes in the striatal adenylate cyclase activity following acute and chronic morphine treatment and during withdrawal.
    Puri SK; Volicer L; Cochin J
    J Neurochem; 1976 Dec; 27(6):1551-4. PubMed ID: 1033988
    [No Abstract]   [Full Text] [Related]  

  • 35. Multiple receptors for dopamine.
    Kebabian JW; Calne DB
    Nature; 1979 Jan; 277(5692):93-6. PubMed ID: 215920
    [No Abstract]   [Full Text] [Related]  

  • 36. Chronic SCH 23390 produces tolerance to morphine extrapyramidal effects.
    De Montis MG; Devoto P; Saba P; Porcella A; Meloni D; Tagliamonte A
    Pharmacol Res Commun; 1988 Dec; 20(12):1115-6. PubMed ID: 2850585
    [No Abstract]   [Full Text] [Related]  

  • 37. Characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the frontal cerebral cortex of the rat. Comparative effects of neuroleptics on frontal cortex and striatal dopamine sensitive adenylate cyclases.
    Bockaert J; Tassin JP; Thierry AM; Glowinski J; Premont J
    Brain Res; 1977 Feb; 122(1):71-86. PubMed ID: 837225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Genotypic differences in the metabolism of brain dopamine and in the dopamine-dependent forms of behavior in mice].
    Skrinskaia IuA; Nikulina EM
    Genetika; 1988 Jul; 24(7):1321-4. PubMed ID: 3181756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of the cAMP/PKA/DARPP-32 signaling pathway is required for morphine psychomotor stimulation but not for morphine reward.
    Borgkvist A; Usiello A; Greengard P; Fisone G
    Neuropsychopharmacology; 2007 Sep; 32(9):1995-2003. PubMed ID: 17251906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of apomorphine on dopamine turnover and adenosine 3',5'-monophosphate content in striatum of morphine-dependent rats.
    Puri SK; Volicer L; Lal H
    Neuropharmacology; 1977 Mar; 16(3):205-9. PubMed ID: 190557
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.